ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HVO Hvivo Plc

10.20
-0.20 (-1.92%)
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.20 -1.92% 10.20 1,267,516 16:35:01
Bid Price Offer Price High Price Low Price Open Price
10.25 10.50 10.375 10.25 10.25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations EUR 62.73M EUR 10.65M EUR 0.0155 6.69 71.45M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:01 UT 5,000 10.20 GBX

Hvivo (HVO) Latest News

Hvivo (HVO) Discussions and Chat

Hvivo Forums and Chat

Date Time Title Posts
11/6/202509:08hVIVO plc9,808
11/4/202508:24Profit warning now likely 13
11/4/202508:24hVIVO5
15/8/202417:32HVIVO (litter free)56
10/4/202407:01HVIVO (litrer free)2

Add a New Thread

Hvivo (HVO) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Hvivo (HVO) Top Chat Posts

Top Posts
Posted at 22/6/2025 09:20 by Hvivo Daily Update
Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 10.40p.
Hvivo currently has 687,014,088 shares in issue. The market capitalisation of Hvivo is £71,243,361.
Hvivo has a price to earnings ratio (PE ratio) of 6.69.
This morning HVO shares opened at 10.25p
Posted at 11/4/2025 15:00 by sikhthetech
KPE

"Good luck with finding that company that scores 10/10 on all fundamentals. It doesn't exist"

Agree, but point is TLY metrics are significantly better than HVO, yet using the same metrics, 1gw/SuperN and mates ramp HVO and deramp TLY.

Everyone needs healthcare, it's not impacted by tariffs, economic conditions etc

TLY.
Chairman(interim), CEO buying shares.
Expectations revenue £85m, ebitda £3.5m

c50%held by IIs and directors

Govn signed agreement with private providers.

Broker target 20p
Current share price 4p

MCap £8m


HVO.
Chairman, dumped his entire holding.
CEO huge options
Significantly slowing.
Chairman doing a runner after just 8 yrs..

Revenues Expectations c£75m

Mcap £110m

Current share price 16p
Broker target 24p
Posted at 03/4/2025 14:22 by sikhthetech
"Panmure Liberum has issued a broker note titled “Healthcare: A ‘safeish’; haven from tariffs.”"

I've been saying "everyone needs healthcare" for years. Regardless of age, status, everyone needs healthcare.

The same comments/metrics apply to TLY, healthcare provider to the NHS.

"firm has set a share price target of 24p."

TLY's broker has a target of 20p. Current share price is 4.5p!!! So which has better upside!!!

Panmure still only 24p for HVO, significantly below the share price that the chairman dumped his entire holding.


The difference is HVO's client's are US based. They are awarding contracts to a UK based company. Totally against Trump's policies.
Trump would prefer US companies to benefit. So why shouldn't a US company setup a facility like HVO in the US???
Posted at 01/4/2025 14:33 by sikhthetech
mk,

"You mentioned 4 shares on that thread saying i must of been in one and i said i was in HVO"


It was obvious to me last year, Jan that you were in HVO and/or Polb, as you were trying to silence me on the, completely unrelated, RACE thread

You were invested here when the share price was 30p and now the share price has crashed, as expected, you're become bitter.
Over a year ago, as I was posting company newsflow, red flags on here, whilst you were trying to silence me on the RACE.
Bullying people off doesn't change facts or company newsflow. It shows your true colours.



monkeymonkey - 07 Jan 2024 - 18:39:28 - 4741 of 6818
I've been reading the boards tonight Sikh here and LSE, why did you say bring on the trolls on here, i don't see any, before yes that's why this board had to change a couple of times, it seem you bring this all on yourself why, cant you see no one is interested on your points of view and i don't see anyone attacking you on TLY especially on lse boards hvo or polb, it seems to me you have an agenda against everybody lol, in fact your still venting now on lse cant you see your wasting your time and no one is interested on what you say, there saying you might have mental health problems and feel for you, i think different stick to what you know on the shares you own and stop annoying others.






"I'm in two more shares now and I've not posted on there site there's no rule saying you must "

There's no rule that you must provide reasons on horses tipped, yet you dislike the fact I don't. The same goes for shares, no one needs to provide well written posts to understand what is going on. Hypocricy is your name.

As evidenced by my red flags, contrarian stance which were presented in points form and have been proven correct.
Posted at 12/3/2025 09:50 by troutisout
Who cares about Friel? Just you and a couple of other posters who cannot seem to let go...CF last sold in July at 29p, the share price remained around that level for 3-4 months, his selling hardly precipitated an immediate crash.
I have been on the end of unenforced large sellers and the share price can drop massively as they get out and that often wipes out investors who are on margin or with stop losses, CF sold and now the price is a lot lower, that is investment picking the right time to buy and more importantly the right time to sell.
I would say the way the share price reacted to CFs sale that he did his best to mitigate any fall and he did sell his shares at 29p so he must have created liquidity or at least have buyers wanting to pay that price for them.
Since then we have had IIs buying and others selling and the share price dropped due to worries over the slippage in orders. I think this is undervalued at the moment and once the market jitters abate this will go back into the 20's
Posted at 10/3/2025 17:35 by sikhthetech
Options would be taken at the highest price the execs think they can get.

I think the CEO believes the current price was right. It then follows the forthcoming newsflow is likely to disappoint again and share price will fall.

As per my assertion, we're closer to my 10p target than the 30p....as predicted.

The rampers have been proven wrong.
1gw and his mates were ramping at 30p... they keep changing the metric to whatever looks the best. No consistency....

Don't take my word for it... Look at Byot 10p to 0.1p, down 99.9% delisted!!
1gw claimed the house broker was being 'conservative' despite the company themselves showing sales had slowed.



sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO
Trout,

"At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs).
So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there"

Wrong.

The expectations were the same when the share price was 10p, only 2 years ago, weren't they?
The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY.

A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!).

I'd expect the share price to be nearer to 10p than 30p.

The newsflow here has been as predicted.
Posted at 10/3/2025 10:03 by 1gw
A few observations on the options.

Max award was 7,227,273. 25% vested on service and 75% on performance, with a single performance criterion being CAGR TSR over 3 years from an 11p reference share price.

It was not clear how long Mo had to exercise the options once they vested. Usually I think a company will say they are exercisable between dates A & B (A being the vesting date and B often being several years after they vest) but in the original notice and in the annual report they give only the vesting date (23/2/25). My guess is therefore he had a relatively short period to exercise them.

Afaics he exercised all that had vested which was 89% of the max amount, or all the service-related amount plus 85% of the max performance-related amount. To hit the 85% of performance-related vesting I think the CAGR TSR must have been calculated as 20.7%. This was from an 11p reference share price.

Stephen Pinkerton has a harder job to get a decent proportion of his award, which is measured against a 17p reference price with a 10% CAGR TSR threshold and has a vesting date of 1 February 2026.

MO's current options have a broader set of performance criteria, being 40% CAGR TSR, 40% CAGR EBITDA and 20% ESG/sustainability (again being 75% of total award). They are measured over 3 years ending 31 December 2026 and will vest on 30 June 2027. TSR element has a 10% CAGR hurdle and 18% needed for max payout but reference share price and measurement period for calculating achieved shareprice are not clear in the original announcement.

I would say the incentive scheme appears to be doing its job. Having exercised the first award Mo now has more equity skin in the game. Although there have been a couple of recent acquisitions, it doesn't look as though MO took any unreasonably risky decisions in order to try to juice the shareprice ahead of the vesting date, although it's not entirely clear what the measurement period for the final shareprice calculation was. Both Mo and Stephen are incentivised to get the shareprice higher over the next couple of years, and Mo's performance criteria broadening out to include EBITDA provides a bit of a check on making decisions which favour short-term shareprice growth over longer-term earnings growth. Having said that, shareprice and EBITDA criteria still provide something of an incentive to make "risky" acquisitions which boost EBITDA (amortisation of the acquisition is excluded) and are well-received in the short-term but may expose the business in the medium-term. It is the board's job to ensure that risks are properly considered and staggering the performance periods for CEO and CFO awards provides some mitigation here.
Posted at 25/2/2025 15:49 by sikhthetech
There you go, getting close to the 10p.

Amazing how trout/1gw/pierre/supernumerary all disappeared, now the share price is crashing.
Moved on to the next one, no doubt.

Oh, Nexn is busy.... That's down 25% in a week!!!



sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO
Trout,

"At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs).
So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there"


Wrong.

The expectations were the same when the share price was 10p, only 2 years ago, weren't they?
The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY.

A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!).

I'd expect the share price to be nearer to 10p than 30p.

The newsflow here has been as predicted.
Posted at 08/1/2025 15:38 by sikhthetech
Yes, getting closer to my 10p target..

Where are the 30p brigade? Trout, 1gw, Pierre, Supernumerary etc etc
Surely given these have fallen 40%, they are loading up????

I see FAB was also pumped/dumped, as predicted.



sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO
Trout,

"At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs).
So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there"


Wrong.

The expectations were the same when the share price was 10p, only 2 years ago, weren't they?
The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY.

A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!).

I'd expect the share price to be nearer to 10p than 30p.

The newsflow here has been as predicted.
Posted at 07/1/2025 17:10 by sikhthetech
The share price is closer to 10p than 30p, isn't it?


sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO
Trout,

"At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs).
So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there"


Wrong.

The expectations were the same when the share price was 10p, only 2 years ago, weren't they?
The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY.

A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!).

I'd expect the share price to be nearer to 10p than 30p.

The newsflow here has been as predicted.
Posted at 31/12/2024 15:31 by sikhthetech
There you go, the company newsflow has been as I predicted a year ago!!!

sp was 25.5p when I posted the post...

sp now at 20.5p. This is despite the supposedly huge new facility, huge buying by IIs, supposedly huge new contracts, supposedly huge potential!!!!

I said I wouldn't buy because they are being talked up and I don't see the potential...
Glad I didn't listen to 1gw and his mates ramping at 30p.



sikhthetech - 02 Jan 2024 - 12:01:49 - 5733 of 9118 hVIVO plc - HVO
chica,

Baldrick is right, those who traded have made more than those who just held.

Facts:
Look at the chart and actual sps.
Last year, in Feb, the share price was 21.5p

Also, hardly any movement year to year.

Out of last 4 years, 3 years the share price ended the year 23-24p. The other, Dec 2022, which was whilst Mo was CEO, it was 10.2p.

Dec 2020 22p
Dec 2021 24p
Dec 2022 10.20p
Feb 2023 21.5p, Dec 2023 23.75p


The current share price is still lower than it was 2.5yrs ago, when I 1st looked at these - coincidentally following a media tip!.

The share price has been falling during the year to move back towards 23p-24p by year end.
Media tips and the share price rises again only to fall again.

I have traded these in the past but don't currently hold as I believe they are hyped. Mo has huge options which are due to exercise in a year, so this is being talked up.

£173m Mcap for a company with expected £60m revenues!!
Hvivo share price data is direct from the London Stock Exchange

Hvivo Frequently Asked Questions (FAQ)

What is the current Hvivo share price?
The current share price of Hvivo is 10.20p
How many Hvivo shares are in issue?
Hvivo has 687,014,088 shares in issue
What is the market cap of Hvivo?
The market capitalisation of Hvivo is GBP 71.45M
What is the 1 year trading range for Hvivo share price?
Hvivo has traded in the range of 6.75p to 30.75p during the past year
What is the PE ratio of Hvivo?
The price to earnings ratio of Hvivo is 6.69
What is the cash to sales ratio of Hvivo?
The cash to sales ratio of Hvivo is 1.14
What is the reporting currency for Hvivo?
Hvivo reports financial results in EUR
What is the latest annual turnover for Hvivo?
The latest annual turnover of Hvivo is EUR 62.73M
What is the latest annual profit for Hvivo?
The latest annual profit of Hvivo is EUR 10.65M
What is the registered address of Hvivo?
The registered address for Hvivo is FLOOR 24, 40 BANK STREET, LONDON, E14 5NR
What is the Hvivo website address?
The website address for Hvivo is www.hvivo.com
Which industry sector does Hvivo operate in?
Hvivo operates in the PHARMACEUTICAL PREPARATIONS sector

Your Recent History

Delayed Upgrade Clock